Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

AVRO

AVROBIO (AVRO)

AVROBIO Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVRO
DateTimeSourceHeadlineSymbolCompany
28/02/202402:50PR Newswire (US)Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
24/02/202408:00Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVROAVROBIO Inc
06/02/202412:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202411:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202411:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202411:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
02/02/202406:25PR Newswire (US)Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
31/01/202408:47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
31/01/202408:07Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
31/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
31/01/202401:05Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
31/01/202400:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
31/01/202400:00Business WireAVROBIO and Tectonic Therapeutic Announce MergerNASDAQ:AVROAVROBIO Inc
10/11/202308:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
04/11/202307:15Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:AVROAVROBIO Inc
11/08/202306:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
12/07/202321:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
12/07/202321:00Business WireAVROBIO to Explore Strategic AlternativesNASDAQ:AVROAVROBIO Inc
04/07/202303:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
15/06/202307:20Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVROAVROBIO Inc
12/06/202321:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
12/06/202321:00Business WireAVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 MillionNASDAQ:AVROAVROBIO Inc
10/06/202306:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
09/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
09/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
09/06/202306:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
09/06/202306:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
09/06/202306:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202302:07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
06/06/202306:25Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
 Showing the most relevant articles for your search:NASDAQ:AVRO